Skip to main content

Day: July 23, 2021

DIVIDEND 15 SPLIT CORP. Financial Results to May 31, 2021

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (“the Company”) announces that its semi-annual financial statements and management report of fund performance for the six months ended May 31, 2021 are now available at www.sedar.com and the Company’s website at www.dividend15.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.dividend15.com.Investor Relations: 1-877-478-2372 Local: 416-304-4443 www.dividend15.com info@quadravest.com

Continue reading

RAB Capital Discloses Investment in Black Iron Inc.

BRENTWOOD, United Kingdom, July 23, 2021 (GLOBE NEWSWIRE) — RAB Capital Holdings Limited (“RAB Capital”), a private investment holding corporation owned by Mr. William Philip Richards, reports that, on July 21, 2021, it purchased 1,500,000 common shares of Black Iron Inc. (BKI:TSX) (“Black Iron”) pursuant to a short form prospectus offering, at a price of $0.40 per share for aggregate consideration of $600,000. RAB Capital now beneficially owns and controls 38,300,000 Black Iron shares (representing approximately 12.68% of the outstanding Shares on a non-diluted and partially-diluted basis). Prior to this investment acquisition transaction RAB Capital beneficially owned 36,800,000 common shares of Black Iron representing approximately 13.5% of the outstanding Shares on a non-diluted and partially-diluted basis. The Black Iron shares...

Continue reading

Clever Leaves to Take Advantage of the Approval to Export Medical Cannabis Flower from Colombia

Export of dry cannabis flower from Colombia has been authorized by a new decree that was signed on July 23rd, 2021, at Clever Leaves’ cultivation facility by President Ivan Duque and his ministers.With flower representing an estimated 50% of global medical cannabis markets, this decree doubles the total addressable market for Clever Leaves’ Colombian operations.1Clever Leaves’ Colombian operation is well-positioned to take advantage of this change, given its 1.8 million square feet of cultivation, CUMCS GACP and Latin America’s only EUGMP certifications for the production of dried flower.Clever Leaves will now be able to offer its clients a comprehensive portfolio of cannabinoid options with its extract, isolate, and flower products from Colombia and its flower product from Portugal.As a trusted B2B partner, Clever Leaves can...

Continue reading

Titanium Corporation Announces it Has Been Granted an Extension to Hold Its Annual and Special Meeting

CALGARY, Alberta, July 23, 2021 (GLOBE NEWSWIRE) — Titanium Corporation Inc. (the “Company” or “Titanium”) (TSX-V: TIC) announces it has been granted an extension by the Court of Queen’s Bench of Alberta pursuant to Section 133(3) of the Canada Business Corporations Act permitting the Company to hold its annual general and special meeting at any time on or before December 30, 2021. The previously announced discussions between key shareholders of Titanium and the Board of Directors of the Company have not yet concluded. These discussions are focused on raising financing for the Company and the Board of Directors is evaluating financing options. Depending on the outcome of these discussions and the evaluation, certain directors of Titanium may remove their names for re-election and the Board of Directors...

Continue reading

Afya Limited Announces Results of Annual General Meeting Held on July 23, 2021

NOVA LIMA, MINAS GERAIS, Brazil, July 23, 2021 (GLOBE NEWSWIRE) — Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 28, 2021 were duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya’s financial statements as of and for the fiscal year ended December 31, 2020; and (2) the approval of the Amended and Restated Memorandum and Articles of Association available at Afya’s website at https://ir.afya.com.br, subject to and with effect from Closing (as that term is defined in the share purchase agreement dated on or about June 7, 2021 between Crescera Educacional II Fundo de Investimento em Participações Multiestratégia and Erste WV Gtersloh Gmbh). About Afya Limited Afya is a leading medical education group in...

Continue reading

Certara’s Vaccine Simulator™ Accurately Predicted Optimal Timing Between Doses for COVID-19

Clinical Study Confirms Quantitative Systems Pharmacology (QSP) Prediction, Showcasing the Power of Biosimulation Technology PRINCETON, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Certara, a global leader in biosimulation, today announced that its Vaccine Simulator accurately predicted that eight weeks was the optimal timing between the first and second dose of COVID-19 vaccines. The Pitch study conducted at Oxford University in the United Kingdom confirmed Certara’s Vaccine Simulator prediction, which was released six months ago. Current dosing for the Pfizer-BioNTech and Moderna vaccines are spaced three and four weeks apart, respectively. “The Pitch study results further validate that Certara’s biosimulation technology is a powerful, predictive tool to understand how vaccines and COVID-19 therapies work, enabling us to get dosing...

Continue reading

Hammond Power Solutions Inc. Completes Acquisition of Mesta Electronics, Inc.

GUELPH, Ontario, July 23, 2021 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS”) today acquired a 100% equity ownership of Mesta Electronics Inc. (“Mesta”), a company in the United States. Mesta is involved in the design and manufacture of standard and custom active filter and induction heating products. Mesta will operate as Mesta Electronics Inc., a subsidiary of Hammond Power Solutions, Inc. Mesta’s annual revenues are expected to be approximately CDN$5,000,000. Bill Hammond, Chief Executive Officer of HPS stated, “We are very pleased with the Mesta acquisition. This company broadens our product offering and manufacturing capabilities in power quality solutions. Mesta has an excellent reputation in the electrical industry for its standard and engineered to order capabilities and quality.” About Hammond Power Solutions...

Continue reading

Churchill Enters Into Definitive Option Agreement to Acquire Florence Lake Ni-Cu-PGE Property From Altius

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) — Further to its news release dated June 25, 2021, Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV:CRI) is pleased to announce that it has entered into a definitive option agreement (the “Option Agreement”) with Altius Resources Inc. (“Altius”) to acquire a 100% undivided interest in certain mining claims comprising the Florence Lake Ni-Cu-PGE property in central Labrador near the coastal community of Hopedale and 175 km south of the Voisey’s Bay mine (the “Florence Lake Property”). The Florence Lake Property is host to several Raglan-type ultramafic volcanic-hosted massive and disseminated sulphide nickel showings, and was last explored by Falconbridge between 1990-1997 during which time approximately 6,250m of drilling in 45 shallow holes were conducted, with drill...

Continue reading

Timbercreek Financial Declares July 2021 Dividend

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that its board of directors (the “Board”) has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on August 13, 2021 to holders of Common Shares of record on July 30, 2021. The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees. Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent...

Continue reading

Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia

RALLY Study Will Stop Enrolling New Participants Following Recommendation from an Interim Analysis Indicating Inadequate Separation from Placebo at Week-14 in the First 50% of Participants, Based on the Original Targeted Study Size Company Plans to Unblind and Report Topline Results in the Fourth Quarter of 2021 Following Completion of Study for Currently Enrolled Participants RALLY Study Follows Announcement in December 2020 of Positive Results from First Phase 3 Study, RELIEF, of TNX-102 SL 5.6 mg for the Management of Fibromyalgia CHATHAM, N.J., July 23, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that the Company has decided to stop enrollment in the Phase 3 RALLY study of TNX-102 SL (cyclobenzaprine HCl sublingual...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.